Skip to main content
ANI PHARMACEUTICALS INC logo

ANI PHARMACEUTICALS INC — Investor Relations & Filings

Ticker · ANIP ISIN · US00182C1036 LEI · 5493000T6CXTND40YH31 US Manufacturing
Open in API
Filings indexed 1,280 across all filing types
Latest filing 2026-05-21 Declaration of Voting R…
Country US United States of America
Listing US ANIP

About ANI PHARMACEUTICALS INC

https://www.anipharmaceuticals.com/

ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company engaged in the development, manufacturing, and marketing of pharmaceutical products. Its portfolio includes high-quality branded and generic prescription drugs, as well as over-the-counter (OTC) medicines. The company serves patients across various therapeutic areas, with a presence in the rare disease market and a strategic focus on expanding its ophthalmology and retina franchise.

Recent filings

Filing Released Lang Actions
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a Form 8-K “Current Report” filed by ANI Pharmaceuticals, Inc. under Item 5.07, detailing the submission of matters to a vote of security holders and providing the vote tally results for each proposal at its Annual Meeting. This matches the definition of a Declaration of Voting Results & Voting Rights Announcement (code DVA).
2026-05-21 English
8-K - ANI PHARMACEUTICALS INC (0001023024) (Filer)
Report Publication Announcement Classification · 87% confidence The document is a Form 8-K current report under Item 7.01 disclosing that an updated investor presentation was published on the company’s website and is attached as Exhibit 99.1. It does not contain the actual presentation content but simply announces its availability. Per the “menu vs. meal” rule, this is an announcement of publication rather than the presentation itself, fitting the Report Publication Announcement definition.
2026-05-13 English
10-Q - ANI PHARMACEUTICALS INC (0001023024) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-08 English
8-K - ANI PHARMACEUTICALS INC (0001023024) (Filer)
Report Publication Announcement Classification · 87% confidence The document is a Form 8-K current report from ANI Pharmaceuticals, Inc. dated May 8, 2026, under Item 2.02 “Results of Operations and Financial Condition.” The 8-K itself is under 5,000 characters and does not include any actual financial results; it merely states that a press release announcing first‐quarter results is furnished as Exhibit 99.1. Per the “menu vs. meal” rule, this is an announcement that a report (the press release/earnings release) has been published and is attached, rather than the substantive report itself. This matches the definition of a Report Publication Announcement (RPA).
2026-05-08 English
ARS - ANI PHARMACEUTICALS INC (0001023024) (Filer)
Annual Report
2026-04-09 English
DEF 14A - ANI PHARMACEUTICALS INC (0001023024) (Filer)
Proxy Solicitation & Information Statement
2026-04-09 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.